시장보고서
상품코드
2049248

혈액투석 시장 : 부문별, 모달리티별, 최종사용자, 지역별(2026-2034년)

Hemodialysis Market Report by Segment, Modality, End-User, and Region 2026-2034

발행일: | 리서치사: 구분자 IMARC | 페이지 정보: 영문 149 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트 등의 Copy&Paste도 불가능합니다.
US $ 3,999 금액 안내 화살표 ₩ 6,100,000
PDF & Excel (5 User License) help
PDF & Excel 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy&Paste가 불가능합니다. 인쇄는 5부까지 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,999 금액 안내 화살표 ₩ 7,626,000
PDF & Excel (Corporate License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy&Paste가 가능합니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,999 금액 안내 화살표 ₩ 9,152,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 혈액투석 시장 규모는 2025년에 974억 달러에 달했습니다. 향후에 대해 IMARC Group은 2034년까지 시장 규모가 1,342억 달러에 달하며, 2026-2034년에 CAGR 3.48%로 성장할 것으로 예측하고 있습니다. 의료 제공자와 투석 장비 제조업체 간의 협력 강화를 통한 치료 보급 촉진, 고혈압 관련 신장 질환의 유병률 증가, 장기 기증 부족, 신장 질환에 대한 인식 증가, 투석에 대한 접근성 향상에 대한 요구 증가 등이 시장을 주도하는 요인 중 일부입니다.

혈액투석은 진행성 신장질환이나 신부전증 환자를 치료하기 위한 생명을 살리는 의료 시술입니다. 이는 신장이 이러한 기능을 효과적으로 수행할 수 없을 때 투석기라는 전용 장치를 이용해 혈액에서 노폐물, 여분의 수분, 전해질을 제거해 주는 것입니다. 혈액투석 중 환자의 혈액은 혈관 접근 부위(일반적으로 외과적으로 만든 누공 또는 이식편)를 통해 체외로 유도되어 투석기로 보내집니다. 혈액은 투석기 내의 반투과성 막을 통해 여과되고, 노폐물과 과도한 물질은 혈액에서 투석액으로 배출됩니다. 여과된 혈액은 다시 환자의 체내로 되돌려집니다. 혈액투석 세션은 보통 몇 시간 동안 지속되며, 일반적으로 일주일에 몇 번씩 진행됩니다. 빈도 및 소요시간은 환자의 구체적인 병력 및 의료진의 지시에 따라 달라질 수 있습니다. 혈액투석은 체내 수분과 전해질 균형을 유지하고, 혈압을 효과적으로 관리하며, 심각한 건강상의 합병증을 유발하는 유해한 노폐물 축적을 방지하는 데 매우 중요한 역할을 합니다. 부담이 크고 평생에 걸친 치료인 경우가 많지만, 혈액투석은 신부전 환자의 삶의 질과 수명을 크게 향상시킬 수 있습니다.

세계 시장은 주로 만성 신장 질환의 유병률 증가에 의해 주도되고 있습니다. 이에 따라 고령화 인구는 신장 관련 문제가 발생하기 쉬워지고 있으며, 이에 따라 혈액투석에 대한 수요가 증가하고 있습니다. 또한 전 세계에서 당뇨병의 확산은 신장 질환 사례에 크게 기여하고 있으며, 혈액투석의 필요성을 증가시키고 있습니다. 이 외에도 비만과 관련된 신장 질환도 혈액투석 치료의 수요를 촉진하고 있습니다. 또한 의료 시설에 대한 접근성이 개선되면서 신장 질환의 진단과 치료가 증가하고 있습니다. 투석 장비와 시술의 기술 혁신은 치료 효율을 향상시키고 있습니다. 또한 신장 건강에 대한 인식이 높아짐에 따라 조기 개입과 투석에 대한 인식이 높아지고 있습니다. 또한 유리한 보험 환급 정책으로 인해 환자들은 혈액투석 치료를 받을 수 있게 되었습니다.

혈액투석 시장 동향과 촉진요인:

의료관광의 증가

의료관광의 확대 추세가 시장을 활성화시키고 있습니다. 첨단화된 의료시설을 갖추고 치료비가 상대적으로 저렴한 국가들은 양질의 혈액투석 서비스를 원하는 환자들을 끌어들이고 있습니다. 의료관광객들은 자국에서 드는 비용의 몇 분의 1에 불과한 비용으로 혈액투석을 포함한 전문적인 치료를 받을 수 있는 지역을 선택하는 경우가 많습니다. 이러한 해외 환자 유입으로 인해 이들의 요구에 부응하기 위해 시설이 잘 갖춰진 투석센터 설립이 필요하게 되었습니다. 의료관광의 거점인 의료 서비스 제공자들은 늘어나는 수요에 대응하기 위해 투석 수용 능력을 확대하고, 숙련된 전문가를 고용하고, 첨단 기술을 도입하고 있습니다. 의료관광이 지속적으로 확대되고 있는 가운데, 해외에서 치료를 받으려는 환자 수가 증가함에 따라 시장이 성장하고 있습니다.

전 세계 투석센터 확대

투석 센터의 글로벌 확장은 시장을 촉진하는 데 있으며, 매우 중요합니다. 다양한 지역에 더 많은 투석 시설이 설립됨에 따라 혈액투석 치료에 대한 접근성이 더욱 광범위하게 확대될 것입니다. 이들 센터는 신장 질환 환자들이 생명 유지에 필수적인 혈액투석 시술을 편리하고 적시에 받을 수 있도록 돕습니다. 투석 센터의 네트워크 확장은 증가하는 환자 수에 대응하고 조기 진단과 조기 개입을 촉진하는 것뿐만 아니라. 이러한 확대는 정기적인 혈액투석을 필요로 하는 사람들에게 보다 접근하기 쉽고 환자 중심의 환경을 조성함으로써 시장 성장을 촉진하고 있습니다. 또한 더 많은 투석 센터의 존재는 경쟁을 촉진하고, 이는 기술 발전과 서비스 개선을 촉진하고, 제공되는 의료 서비스의 전반적인 품질을 향상시키고, 혈액투석 서비스에 대한 수요를 증가시키고 있습니다.

신장 전문의 부족

신장 전문의의 부족이 시장을 주도하고 있습니다. 늘어나는 신장 질환을 관리할 수 있는 신장 전문의가 부족하여 혈액투석 서비스에 대한 수요가 증가하고 있습니다. 이 부족을 해결하기 위해 의료 서비스 제공자들은 혈액투석 서비스 제공을 확대하고 새로운 센터를 개설하여 치료 능력을 강화하고 있습니다. 이러한 현상은 원격 진료 솔루션의 개발 및 도입을 촉진하여 혈액투석 환자의 원격 진료 및 모니터링을 가능하게 하고 있습니다. 또한 이러한 부족은 신장 의료의 공백을 메우기 위해 의료기관이 의료진을 위한 교육 및 기술 향상 프로그램에 투자하는 계기가 되고 있습니다. 신장 전문의 부족에 대응하기 위한 이러한 협력적 노력은 혈액투석 치료를 받을 수 있는 기회를 확대하고, 더 많은 환자들이 신장 건강을 효과적으로 관리하기 위해 혈액투석 서비스에 의존하게 됨으로써 궁극적으로 시장 성장을 촉진하고 있습니다.

목차

제1장 서문

제2장 조사 범위와 조사 방법

제3장 개요

제4장 서론

제5장 세계의 혈액투석 시장

제6장 시장 내역 : 부문별

제7장 시장 내역 : 모달리티별

제8장 시장 내역 : 최종사용자별

제9장 시장 내역 : 지역별

제10장 SWOT 분석

제11장 밸류체인 분석

제12장 Porter's Five Forces 분석

제13장 경쟁 구도

KSA 26.06.11

The global hemodialysis market size reached USD 97.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 134.2 Billion by 2034, exhibiting a growth rate (CAGR) of 3.48% during 2026-2034. The increasing collaborations between healthcare providers and dialysis manufacturers promote treatment availability, the rising prevalence of hypertension-related kidney diseases, the limited organ availability, the growing awareness about kidney diseases, and advocacy for improved dialysis access are some of the factors propelling the market.

Hemodialysis is a life-saving medical procedure for treating individuals with advanced kidney disease or kidney failure. It involves using a specialized machine called a dialyzer to remove waste, excess fluids, and electrolytes from the blood when the kidneys can no longer perform these functions effectively. During hemodialysis, a patient's blood is diverted from their body through a vascular access point (usually a surgically created fistula or graft) to the dialyzer. The blood is filtered through a semipermeable membrane within the dialyzer, allowing waste and excess substances to pass out of the blood and into a dialysate solution. The filtered blood is then returned to the patient's body. Hemodialysis sessions typically last several hours and are generally performed multiple times a week. The frequency and duration depend on the patient's specific medical condition and the advice of their healthcare provider. It plays a crucial role in maintaining the body's balance of fluids and electrolytes, effectively managing blood pressure, and preventing the accumulation of harmful waste products that would otherwise lead to serious health complications. While it is a demanding and often lifelong treatment, hemodialysis significantly enhances the quality of life and longevity of individuals with kidney failure.

The global market is majorly driven by the increasing incidence of chronic kidney diseases. In line with this, the rising aging population is more susceptible to kidney-related issues, leading to a higher need for hemodialysis. Furthermore, the global diabetes epidemic contributes significantly to kidney disease cases, necessitating hemodialysis. Apart from this, obesity-related kidney diseases fuel the demand for hemodialysis treatments. Moreover, better access to medical facilities has led to increased diagnosis and treatment of kidney diseases. Technological innovations in dialysis machines and procedures improve treatment efficiency. Besides, the escalating awareness about kidney health encourages early intervention and dialysis. Additionally, favorable reimbursement policies enable patients to afford hemodialysis treatments.

HEMODIALYSIS MARKET TRENDS/DRIVERS:

Increasing medical tourism

The growing trend of medical tourism is stimulating the market. Countries with advanced healthcare facilities and lower treatment costs attract patients seeking high-quality hemodialysis services. Medical tourists often choose regions where they can access specialized care, including hemodialysis, at a fraction of the cost they would incur in their home countries. This influx of international patients necessitates the establishment of well-equipped dialysis centers to cater to their needs. Healthcare providers in medical tourism hubs expand their dialysis capacities, employ skilled professionals, and adopt advanced technologies to accommodate the rising demand. As medical tourism continues to rise, the market experiences growth due to the increased volume of patients seeking treatment away from home.

Expansion of dialysis centers worldwide

The global expansion of dialysis centers is pivotal in propelling the market. With more dialysis facilities being established across different regions, access to hemodialysis treatments becomes more widespread. These centers ensure patients with kidney diseases have convenient and timely access to life-sustaining hemodialysis procedures. The expanded network of dialysis centers not only accommodates the growing patient population and facilitates early diagnosis and intervention. This expansion drives market growth by creating a more accessible and patient-centered environment for individuals needing regular hemodialysis sessions. Furthermore, the presence of a broader range of dialysis centers fosters competition, which, in turn, encourages technological advancements and service improvements, enhancing the overall quality of care provided and fueling the demand for hemodialysis services.

Shortage of nephrologists

The shortage of nephrologists is bolstering the market. With fewer nephrologists available to manage the increasing number of kidney disease cases, the demand for hemodialysis services increases. To address this scarcity, healthcare providers expand their hemodialysis offerings, opening new centers and increasing treatment capacities. This phenomenon also encourages the development and implementation of telemedicine solutions, enabling remote consultations and monitoring of hemodialysis patients. Additionally, the shortage prompts healthcare institutions to invest in training and upskilling programs for medical professionals to address the gap in nephrology care. This collaborative effort to cope with the nephrologist shortage results in the wider availability of hemodialysis treatments, ultimately driving the market's growth as more patients rely on these services to manage their kidney health effectively.

HEMODIALYSIS INDUSTRY SEGMENTATION:

Breakup by Segment:

  • Hemodialysis Product
    • Machines
    • Dialyzers
    • Others
  • Hemodialysis Service
    • In-center Services
    • Home Services

Hemodialysis service dominates the market

The hemodialysis service segment is bolstering the market due to its essential role in delivering life-sustaining treatments to individuals with kidney diseases. As the prevalence of kidney-related conditions rises, the demand for hemodialysis services escalates. These services encompass a comprehensive range of treatments, including pre-dialysis assessments, dialysis sessions, post-treatment care, and patient education. The convenience of receiving expert care within specialized centers or even through home-based setups attracts patients seeking efficient and regular hemodialysis.

Moreover, the adoption of advanced technologies and personalized treatment plans within hemodialysis services enhances treatment effectiveness and patient outcomes. As healthcare providers continue to invest in expanding and refining their hemodialysis service offerings, the segment significantly contributes to market growth by ensuring accessible, quality care for patients dependent on these life-saving procedures.

Breakup by Modality:

  • Conventional Hemodialysis
  • Short Daily Hemodialysis
  • Nocturnal Hemodialysis

Conventional hemodialysis dominates the market

The conventional hemodialysis modality drives market growth due to its widespread adoption and established efficacy in treating kidney diseases. This modality involves using a dialysis machine to filter and cleanse the blood, removing waste and excess fluids. Its long-standing presence and familiarity in medical practice make it a preferred choice for patients and healthcare providers. As the prevalence of kidney diseases increases, the demand for effective treatment options escalates, leading to the continued prominence of conventional hemodialysis.

Additionally, technological advancements have improved dialysis machine efficiency, safety, and patient comfort. These enhancements further bolster the appeal of conventional hemodialysis as a reliable and proven method for managing kidney-related conditions, thereby contributing significantly to the market's overall growth.

Breakup by End-User:

  • Hospitals
  • Independent Dialysis Centres

Hospitals with advanced medical infrastructure and expert staff provide comprehensive hemodialysis services to multiple patients. Their ability to handle complex cases, offer integrated care, and provide emergency services contributes to the market's expansion.

On the other hand, independent dialysis centers offer specialized care focused solely on hemodialysis. These centers promote convenience and tailored treatment plans, catering to the specific needs of patients. Their growth stems from increased patient preference for outpatient care, flexibility, and proximity to home.

Both segments foster competition, encouraging advancements in treatment quality, technology, and patient experience. As demand for hemodialysis rises, the combined efforts of hospitals and independent centers ensure broader access to life-sustaining treatments, propelling the market forward and meeting the diverse needs of individuals with kidney diseases.

Breakup by Region:

  • Asia Pacific
  • Europe
  • North America
  • Middle East and Africa
  • Latin America

North America exhibits a clear dominance, accounting for the largest hemodialysis market share

The report has also provided a comprehensive analysis of all the major regional markets, which include Asia Pacific, Europe, North America, Middle East and Africa, and Latin America. According to the report, North America was the largest market for hemodialysis.

The North American region is a significant driver of market growth due to its advanced healthcare infrastructure, increasing prevalence of kidney diseases, and heightened awareness about renal health. Well-established medical facilities and technological advancements enable the delivery of high-quality hemodialysis services. A rising aging population and lifestyle-related factors contribute to the growing incidence of kidney diseases, thereby propelling the demand for effective treatments like hemodialysis.

Moreover, North America's proactive healthcare policies and reimbursement systems facilitate patient access to these vital procedures. The region's emphasis on research and development leads to continuous improvements in hemodialysis techniques, equipment, and patient care. The partnership between healthcare institutions and industry players further accelerates innovation. The region's robust healthcare ecosystem, coupled with increasing patient needs, ensures the steady expansion of the market.

COMPETITIVE LANDSCAPE:

Top companies are strengthening the market through innovative products, strategic expansions, and commitment to improving patient outcomes. These companies invest in research and development, continuously introducing advanced dialysis machines, equipment, and solutions that enhance treatment effectiveness and patient comfort. Their focus on technological innovation, such as improved filtration systems and connectivity features, raises the quality of care. Moreover, these companies engage in strategic partnerships and acquisitions, expanding their global reach and enhancing their service portfolios. By collaborating with healthcare institutions and professionals, they facilitate the establishment of specialized dialysis centers and enable easier access to treatments. Additionally, top companies prioritize patient education and support, offering training programs and resources to medical staff and patients. This approach fosters awareness, adherence, and better management of kidney-related conditions, ultimately driving sustained market growth.

The report has provided a comprehensive analysis of the competitive landscape in the hemodialysis market. Detailed profiles of all major companies have also been provided.

  • Baxter International
  • Asahi Kasei Corporation
  • B. Barun Melsungen
  • DaVita
  • Cantel Medical Corporation
  • Fresenius Medical Care
  • Nipro Corporation
  • Rockwell Medical
  • Medivators
  • Toray Medical Company Ltd.
  • Nikkiso Co. Ltd.
  • Surni Group
  • Gambro
  • Satellite Healthcare Inc.
  • Renacon Pharma Ltd.

Key Questions Answered in This Report

1. How big is the global hemodialysis market?

2. What is the expected growth rate of the global hemodialysis market during 2026-2034?

3. What are the key factors driving the global hemodialysis market?

4. What has been the impact of COVID-19 on the global hemodialysis market?

5. What is the breakup of the global hemodialysis market based on the segment?

6. What is the breakup of the global hemodialysis market based on the modality?

7. What are the key regions in the global hemodialysis market?

8. Who are the key players/companies in the global hemodialysis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hemodialysis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Segment
    • 5.4.1 Market Breakup by Product
    • 5.4.2 Market Breakup by Service
  • 5.5 Market Breakup by Modality
  • 5.6 Market Breakup by End-User
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Segment

  • 6.1 Hemodialysis Product
    • 6.1.1 Market Trends
    • 6.1.2 Market Breakup by Product
      • 6.1.2.1 Machines
      • 6.1.2.2 Dialyzers
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Hemodialysis Service
    • 6.2.1 Market Trends
    • 6.2.2 Market Breakup by Service
      • 6.2.2.1 In-center Services
      • 6.2.2.2 Home Services
    • 6.2.3 Market Forecast

7 Market Breakup by Modality

  • 7.1 Conventional Hemodialysis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Short Daily Hemodialysis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Nocturnal Hemodialysis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Independent Dialysis Centres
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 Asia Pacific
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 North America
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porter's Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Baxter International
    • 13.3.2 Asahi Kasei Corporation
    • 13.3.3 B. Barun Melsungen
    • 13.3.4 DaVita
    • 13.3.5 Cantel Medical Corporation
    • 13.3.6 Fresenius Medical Care
    • 13.3.7 Nipro Corporation
    • 13.3.8 Rockwell Medical
    • 13.3.9 Medivators
    • 13.3.10 Toray Medical Company Ltd.
    • 13.3.11 Nikkiso Co. Ltd.
    • 13.3.12 Surni Group
    • 13.3.13 Gambro
    • 13.3.14 Satellite Healthcare Inc.
    • 13.3.15 Renacon Pharma Ltd.
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기